首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Current oncology reports

缩写:CURR ONCOL REP

ISSN:1523-3790

e-ISSN:1534-6269

IF/分区:5.2/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1925
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Sung-Soo Park,Eui-Soon Kim,Jong-Chan Youn et al. Sung-Soo Park et al.
Purpose of review: This review aims to explore key clinical considerations for prescribing exercise in individuals with multiple myeloma (MM) and to evaluate current evidence to develop exercise regimens that prioritize b...
Yongxin Guo,Eric O Aboagye,Dorothy M Gujral Yongxin Guo
Purpose of review: Radiotherapy (RT) is a mainstay treatment strategy for patients with radically treatable head and neck cancer (HNC). Efforts to personalize RT have spanned decades, yielding variable results across diff...
Anagha J Deshpande,Javier Munoz,Razelle Kurzrock Anagha J Deshpande
Purpose of review: Cancer is a leading cause of death worldwide. The process to develop new anti-cancer drugs is long and arduous. Therefore, additional strategies for drug development could involve drug repositioning, i....
Manraj Singh Sra,Parth Sharma,Varun Raj Passi et al. Manraj Singh Sra et al.
Purpose of review: Financial toxicity from cancer treatment is a significant barrier to equitable care and an important clinical and public health concern. This scoping review examines global patterns in the assessment of...
Faris Najdawi,Samuel Lassiter,Alina Gandrabur et al. Faris Najdawi et al.
Purpose: Social determinants of health are increasingly recognized as key contributors to disparities in healthcare access and outcomes. With robotic-assisted radical prostatectomy now widely adopted as the preferred surg...
Michele Maffezzoli,Jason Lau,Samuel Justin et al. Michele Maffezzoli et al.
Purpose of review: The treatment landscape for advanced non-small cell lung cancer (NSCLC) with common EGFR mutations has evolved significantly, with osimertinib established as the first-line standard. Two recent phase II...
Sarafina Urenna Otis,Giuseppe Luigi Banna,Akash Maniam Sarafina Urenna Otis
Purpose of review: This review explores the use of perioperative immunotherapy for early-stage non-small cell lung cancers (NSCLCs), highlighting key recent developments in the field, questions that remain, and perspectiv...
Kartik Gupta,Abu Bakar Butt,Ashley Farrell et al. Kartik Gupta et al.
Background: Colorectal cancer (CRC) is the third most common cancer globally, with 25-30% of patients eventually developing liver metastases (CRLM). These metastases worsen prognosis, emphasizing the need for multidiscipl...
Piotr Remiszewski,Eryk Siedlecki,Marlena Wełniak-Kamińska et al. Piotr Remiszewski et al.
Purpose of review: Sarcomas are a heterogeneous group of over 170 malignant tumours of mesenchymal origin. The poor prognosis highlights the need for novel therapeutic strategies. Preclinical modelling is essential, yet c...
Bin Wang,Limin Xu,Menglong Rui Bin Wang
Purpose of review: Papillary thyroid carcinoma (PTC) is the most prevalent form of thyroid malignancy. While it is widely regarded as having a beneficial prognosis, effective therapies at the advanced stage or metastatic ...